#HREE Harena Resources PLC – First Day of Dealings
Citius Resources plc is pleased to announce the completion of its acquisition of Harena Resources Limited and the admission of its enlarged share capital of 413,884,352 ordinary shares of 0.5 pence each (“Ordinary Shares”) at an issue price of 3 pence each (“Issue Price”) to trading on the Equity Shares (transition) category of the Official […]
#HREE Harena Resources Plc – Result of AGM
Citius Resources plc is pleased to announce that at the Company’s Annual General Meeting held earlier today, all resolutions proposed, including the special resolutions, were duly passed. Accordingly, the proposals set out in the Prospectus dated 26 February 2025 are now expected to complete, conditional on Admission, at 8.00 a.m. on 21 March 2025. Change […]
Citius Resources #CRES – Interim Financial Statements For the six month period ended 31 October 2024
The Company is pleased to announce its Interim Results for the six-month period to 31 October 2024. For further information please contact Citius Resources Plc Cameron Pearce (Director) www.Citiusresources.co.uk Tel: +44 (0)1624 681 250 info@citiusresources.co.uk Tavira Securities Limited Jonathan Evans Tel: +44(0)20 7330 1833 Jonathan.evans@tavirasecurities.com Shard Capital Partners Damon Health Tel: +44(0)20 7186 9927 […]
Citius Resources #CRES – Annual Report
The Board of Citius Resources Plc if leased to announce its annual report and audited financial results for the year ended 30 April 2024. The annual report, Notice of Annual General Meeting & Proxy form will be posted to shareholders and available at the Company’s website https://citiusresources.co.uk/ Citius Resources Plc Cameron Pearce Tel: +44 (0)1624 […]
Quoted Micro 13 June 2022
AQUIS STOCK EXCHANGE Psych Capital (PSY) floated on Aquis so that it can take advantage of the opportunities in the fast-growing psychedelic medicines sector. Management is seeking to invest in early-stage companies, where it can obtain a significant minority stake. Psych Capital raised £810,000 at 5p a share. Pro forma net assets are £2m. Psych […]